In 2017, Aapryl was launched as a financial technology company that provides investors with cutting edge tools which integrate our patent pending methodology for a better way to identify investment managers, build portfolios, and manage risk. Additionally, Aapryl has a Manager Diagnostic analytical tool for investment managers wanting to understand how they are being viewed by investors and consultants, comparing their results relative to their peers. Because many systems that investors use provide statistics on a manager’s past, investors are often choosing investment managers without any insight into how they might perform going forward. Aapryl solves this problem by leveraging a unique patent pending methodology that allows investors to identify managers that are most likely to be successful in the future. We built the methodology by applying years of research as practitioners which has led us to develop statistical methodologies that are predictive of future results.
Aapryl’s unique approach allows investors to:
- Distinguish truly skillful investment managers.
- Rank managers by criteria that is predictive of future performance.
- Improve the efficiency of the manager selection process
Aapryl is a subsidiary of Xponance, the successor firm representing the integration of two legacy firms, FIS Group, Inc. and Piedmont Investment Advisors, Inc. Xponance is a multi-strategy investment firm whose primary goal is to be a trusted client solutions partner. The name is derived from the word “exponent” and dually connotes our core objectives—to be a zealous champion for our clients; and to provide higher level engagement and a broader array of solutions to meet their investment needs. We are employee owned by women and diverse professionals, whose common passion is to do the right thing for our clients and each other.
For more information about Xponance and its services click here